Last Price | 777.30 | Max Price | 1007.00 |
Min Price | 695.10 | 1 Year return | -17.13 |
Sector | Consumer Goods | Subsector | Personal Goods |
Annual report 2015 |
Contact info:Street: Novo AllePostbox: 2880City: BagsvaerdCountry: DenmarkPhone: 45-44-448888Website: www.novonordisk.comCEO: Lars Rebien SoerensenCFO: Jesper Brandgaard
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 122,021 | 848,890 | 14.37 % |
2020 | 126,946 | 763,149 | 16.63 % |
2021 | 140,800 | 886,748 | 15.88 % |
2022 | 176,954 | 1,017,866 | 17.38 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
Analysts expect record sales Novo Nordisk
Analysts expect over 2018 decreasing revenue Novo Nordisk
Novo Nordisk strong outperformer in Denmark
Analysts foresee more revenue Novo Nordisk
2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Novo Nordisk has it' headquarter based in Bagsvaerd. Novo Nordisk is mostly active in the personal goods sector. The CEO of Novo Nordisk is Lars Rebien Soerensen. Jesper Brandgaard runs the company as a CFO. Over the past 10 years the global personal goods companies gained around 51 percent. Measured since 2011 the sector is 36 percent higher and over the past 12 months (December 2015-2016) there is a minus of 51 percent.
Over the period from December 2015 till December 2016 the stock lost around 35 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 97 percent. Novo Nordisk's revenues between 2011 and 2015 were quite unstable and moved between 22,21 billion euros and 38,29 billion euros. Novo Nordisk's net results between 2011 and 2015 were very fluctuating and moved between 17,1 billion euros and 34,86 billion euros.
Over the past 5 years the Danish company paid out dividends. On average the Novo Nordisk stock yielded a delivered a dividend yield of around 22,3 percent over the past 5 years.
At the end of 2015 Novo Nordisk employed at around 40,96 thousand people.
Last year the balance sheet of the Danish company was worth 91,8 billion euros. Last year the total debt of the company was 44,83 billion euros. This equals around 48,83 percent of the total balance sheet. The Danish company's price/earnings-ratio was 21. So the market valued the stock at 21 times the 2015' earnings per share. Based on the classical stock valuation theories the Danish stock can be seen as a value stock.
At the end of 2015 the Danish company's market capitalization equaled around 1029,08 billion euros. At the end of 2015 the Danish company had around 2,6 billion stocks listed on the stock exchange(s).
All Novo Nordisk's annual reports can be found here. More information about Novo Nordisk can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
107,927
|
111,780
|
111,696
|
111,831
|
122,021
|
126,946
|
Costs |
73,067
|
73,855
|
73,566
|
73,203
|
83,070
|
84,808
|
Profit |
34,860
|
37,925
|
38,130
|
38,628
|
38,951
|
42,138
|
Margin of profit |
32.30
|
33.93
|
34.14
|
34.54
|
31.92
|
33.19
|
ROI |
74.22
|
83.78
|
76.54
|
74.52
|
67.63
|
66.54
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
46,969
|
45,269
|
49,815
|
51,839
|
57,593
|
63,325
|
Debt |
44,830
|
52,270
|
52,540
|
58,930
|
68,019
|
81,597
|
Total assets |
91,799
|
97,539
|
102,355
|
110,769
|
125,612
|
144,922
|
Solvency |
51.17
|
46.41
|
48.67
|
46.80
|
45.85
|
43.70
|
Cash |
20,465
|
20,699
|
18,852
|
15,638
|
14,966
|
12,104
|
Cashflow |
38,287
|
48,314
|
41,168
|
45,028
|
46,782
|
51,951
|
Employees |
40,000
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
2.70
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.85
|
0.92
|
0.78
|
0.76
|
0.69
|
0.64
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
399.90
|
254.70
|
334.50
|
297.90
|
386.65
|
Eps |
14.96
|
15.39
|
15.93
|
16.38
|
18.01
|
Price/earnings-ratio |
26.73
|
16.55
|
21.00
|
18.19
|
43.16
|
Dividend |
7.60
|
7.85
|
8.15
|
8.35
|
9.10
|
Dividend % |
1.90 %
|
3.08 %
|
2.44 %
|
2.80 %
|
1.17 %
|
Payout % |
0.51
|
0.51
|
0.51
|
0.51
|
0.51
|
Book value |
23.02
|
26.13
|
27.92
|
31.73
|
35.67
|
Market to book |
0.06
|
0.10
|
0.08
|
0.11
|
0.05
|
Cashflow per stock |
24.56
|
21.59
|
24.25
|
25.78
|
29.26
|
Stocks |
1,967
|
1,907
|
1,857
|
1,815
|
1,776
|
Market Cap |
786.562.01
|
485.601.85
|
621.166.50
|
540.688.50
|
1.380.096.15
|
Date
|
Price
|
---|---|
17 Dec 2024
|
777.30
|
10 Dec 2024
|
782.30
|
06 Dec 2024
|
771.00
|
03 Dec 2024
|
775.80
|
29 Nov 2024
|
747.60
|
27 Nov 2024
|
758.80
|
13 Nov 2024
|
748.90
|
08 Nov 2024
|
730.00
|
05 Nov 2024
|
752.60
|
31 Oct 2024
|
771.50
|
29 Oct 2024
|
770.60
|
23 Oct 2024
|
801.00
|
19 Oct 2024
|
807.20
|
16 Oct 2024
|
803.20
|
14 Oct 2024
|
820.20
|
05 Oct 2024
|
778.20
|
02 Oct 2024
|
798.20
|
27 Sep 2024
|
834.80
|
20 Sep 2024
|
898.20
|
17 Sep 2024
|
922.10
|
13 Sep 2024
|
914.20
|
28 Aug 2024
|
904.10
|
26 Aug 2024
|
903.20
|
23 Aug 2024
|
921.50
|
11 Aug 2024
|
918.60
|
07 Aug 2024
|
828.40
|
05 Aug 2024
|
848.70
|
01 Aug 2024
|
912.00
|
30 Jul 2024
|
884.20
|
26 Jul 2024
|
881.60
|